Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
15.20
Dollar change
+0.04
Percentage change
0.26
%
IndexRUT P/E- EPS (ttm)-0.70 Insider Own1.16% Shs Outstand127.37M Perf Week-2.19%
Market Cap1.94B Forward P/E109.31 EPS next Y0.14 Insider Trans-0.76% Shs Float126.12M Perf Month-5.77%
Income-87.97M PEG- EPS next Q-0.04 Inst Own99.26% Short Float5.78% Perf Quarter-26.18%
Sales591.64M P/S3.28 EPS this Y97.05% Inst Trans-4.36% Short Ratio6.98 Perf Half Y23.48%
Book/sh7.39 P/B2.06 EPS next Y4030.19% ROA-5.14% Short Interest7.29M Perf Year-12.34%
Cash/sh3.25 P/C4.67 EPS next 5Y- ROE-9.07% 52W Range11.03 - 21.22 Perf YTD-6.06%
Dividend Est.- P/FCF- EPS past 5Y- ROI-5.68% 52W High-28.37% Beta1.09
Dividend TTM- Quick Ratio5.95 Sales past 5Y17.35% Gross Margin37.87% 52W Low37.81% ATR (14)0.65
Dividend Ex-Date- Current Ratio6.20 EPS Y/Y TTM39.65% Oper. Margin-16.34% RSI (14)48.34 Volatility3.47% 3.85%
Employees2100 Debt/Eq0.65 Sales Y/Y TTM16.07% Profit Margin-14.87% Recom1.46 Target Price21.70
Option/ShortYes / Yes LT Debt/Eq0.64 EPS Q/Q37.44% Payout- Rel Volume0.75 Prev Close15.16
Sales Surprise1.97% EPS Surprise221.46% Sales Q/Q12.15% EarningsFeb 20 AMC Avg Volume1.04M Price15.20
SMA20-1.28% SMA50-1.00% SMA200-2.75% Trades Volume787,191 Change0.26%
Date Action Analyst Rating Change Price Target Change
Dec-29-23Reiterated BTIG Research Buy $25 → $21
Aug-21-23Upgrade Stephens Equal-Weight → Overweight $18
May-16-23Downgrade Raymond James Outperform → Mkt Perform
May-09-23Upgrade BTIG Research Neutral → Buy $25
Feb-24-23Upgrade The Benchmark Company Hold → Buy $20
Feb-01-23Upgrade Needham Hold → Buy $15
Aug-26-22Downgrade The Benchmark Company Buy → Hold
Aug-22-22Downgrade Needham Buy → Hold
Jun-03-22Initiated Piper Sandler Overweight $13
Mar-29-22Downgrade Stephens Overweight → Equal-Weight $34 → $16
Mar-27-24 08:30AM
Mar-20-24 12:00PM
09:55AM
07:00AM
Mar-01-24 07:05AM
08:12AM Loading…
Feb-29-24 08:12AM
Feb-28-24 09:55AM
Feb-21-24 09:57AM
06:38AM
Feb-20-24 07:00PM
05:35PM
04:39PM
04:37PM
04:05PM
Feb-01-24 07:05AM
09:15AM Loading…
Jan-30-24 09:15AM
07:05AM
Jan-12-24 05:20AM
Jan-02-24 07:05AM
Dec-28-23 04:30PM
03:08PM
12:07PM
08:10AM
Dec-05-23 08:00AM
Nov-14-23 07:00AM
Nov-13-23 09:55AM
Nov-07-23 09:01AM
Nov-06-23 09:00PM
06:10PM
04:33PM
04:05PM Loading…
04:05PM
Nov-01-23 10:01AM
Oct-30-23 03:46PM
10:00AM
Oct-27-23 09:55AM
Oct-24-23 07:00AM
05:20AM
02:18AM
Oct-18-23 08:26AM
Oct-17-23 09:20AM
09:15AM
Oct-13-23 12:00PM
Aug-08-23 11:30AM
09:22AM
07:00AM
Jul-27-23 07:00AM
Jul-18-23 07:10AM
Jun-29-23 07:00AM
Jun-21-23 08:00PM
Jun-15-23 04:45PM
Jun-08-23 01:36PM
Jun-06-23 08:02AM
Jun-05-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-17-23 08:16AM
May-16-23 06:59AM
May-10-23 01:26AM
May-09-23 01:39PM
May-08-23 06:15PM
05:02PM
04:05PM
May-03-23 07:00AM
May-01-23 06:29AM
Apr-26-23 08:00PM
Apr-17-23 07:00AM
Apr-14-23 06:51AM
Apr-11-23 07:00AM
Apr-06-23 07:00AM
Mar-27-23 07:00AM
Mar-22-23 08:00AM
Mar-21-23 08:06AM
Mar-19-23 06:24AM
Mar-16-23 07:00AM
Mar-13-23 07:00AM
Feb-28-23 07:00AM
Feb-23-23 03:34PM
03:32PM
10:05AM
07:00AM
Feb-06-23 07:00AM
07:00AM
Dec-12-22 09:55AM
Dec-05-22 07:50PM
07:35PM
Nov-21-22 07:00AM
Nov-18-22 09:20AM
Nov-11-22 05:36PM
09:30AM
Nov-08-22 08:45AM
07:00AM
Nov-07-22 04:35PM
Nov-02-22 10:00AM
Nov-01-22 10:01AM
Oct-28-22 07:00AM
Oct-13-22 07:00AM
Oct-12-22 07:44AM
Sep-30-22 10:45AM
Sep-07-22 02:00AM
Aug-22-22 11:51AM
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TETRAULT LYNN A.DirectorMar 04 '24Sale15.976,11297,57950,062Mar 06 04:26 PM
Olivo Alicia CGeneral CounselFeb 15 '24Sale14.962,58738,71334,866Feb 20 04:32 PM
Olivo Alicia CGeneral CounselNov 17 '23Sale18.392,66949,08337,140Nov 20 04:33 PM
TETRAULT LYNN A.DirectorMay 22 '23Option Exercise11.601,50717,48156,174May 24 05:29 PM